Skip to main content
NXGL
NASDAQ Industrial Applications And Services

NexGel Q2 Revenue $3.69M, Net Loss $2.87M; Resolicits Shareholder Approval for Reverse Split

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.5
Mkt Cap
$6.673M
52W Low
$0.33
52W High
$2.89
52W Position info
51% above low
Off High info
83% below high
Rel. Volume info
5.2× avg
Market data snapshot near publication time

NXGL sits 51% above its 52-week low of $0.33 on elevated volume (5.2× avg).

Summary

NexGel reported Q2 revenue of $3.69 million and a net loss of $2.87 million, with integration challenges and a $795,000 backlog. The company will resolicit shareholder approval for a reverse split and authorized share increase as standalone proposals.


Key Events · Earnings and Guidance · NXGL

  • Q2 Revenue and Loss

    Revenue of $3.69 million with a net loss of $2.87 million, including $756,554 in intangible amortization, $273,710 in transaction expenses, and $144,495 for SilverSeal recall.

  • BioNX Surgical Backlog

    Supply chain constraints have led to a current BioNX Surgical backlog of approximately $795,000, slowing the integration of the Celularity acquisition.

  • Proxy Resolicitation

    The company will resolicit shareholder approval for an authorized share increase and reverse split as standalone proposals, targeting completion in late September 2026.

  • Restricted Cash Released

    Approximately $710,000 of restricted cash related to ATW Partners was released and returned to the company, concluding that business relationship.


Analysis · NXGL · Industrial Applications And Services

NexGel's Q2 results show slower-than-expected integration of BioNX Surgical, with a $795,000 backlog and supply chain constraints. The company also disclosed it will resolicit shareholder approval for an authorized share increase and reverse split as standalone proposals after the prior proxy failed due to broker non-votes. This is critical because the company faces a going concern warning and potential defaults on $13.9M in convertible notes, making the capital structure changes essential for survival.

At the time of this filing, NXGL was trading at $0.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $6.7M. The 52-week trading range was $0.33 to $2.89. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NXGL - Latest Insights

NXGL
Aug 17, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.5008
Real-time Price: $0.500 info
Change: -$0.0008 (-0.16%) info
Market Cap: $6.673M info
NXGL
Aug 14, 2026, 7:40 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $0.530
Real-time Price: $0.500 info
Change: -$0.030 (-6%) info
Market Cap: $6.673M info
NXGL
Aug 14, 2026, 5:31 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.572385
Real-time Price: $0.500 info
Change: -$0.072385 (-13%) info
Market Cap: $6.673M info
NXGL
Aug 05, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.405
Real-time Price: $0.500 info
Change: +$0.095 (+23%) info
Market Cap: $6.673M info
NXGL
Jul 02, 2026, 5:23 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $0.5646
Real-time Price: $0.500 info
Change: -$0.0646 (-11%) info
Market Cap: $6.673M info